RNA, U4 small nuclear 69, pseudogene (RNU4-69P)

RNU4-69P (RNA, U4 small nuclear 69, pseudogene) is classified as a *pseudogene* of the U4 small nuclear RNA (snRNA) gene family[1][2]. Pseudogenes are segments of DNA that structurally resemble known genes but are typically non-functional due to sequence alterations such as insertions, deletions, or premature stop codons[1][2]. RNU4-69P shares sequence similarity with active U4 snRNA genes but is not known to be transcribed into a functional RNA product or to have a role in spliceosome function. There is no evidence linking RNU4-69P to human disease, therapeutic targeting, or use as a biomarker[1][2]. Notes on Target Status and Nomenclature: - The U4 small nuclear RNAs (such as RNU4-2) are functional components of the spliceosome and are implicated in human disease when mutated[3][4][5][6][7]; however, RNU4-69P refers specifically to a *pseudogene* copy, not to the functional snRNA gene. - As a pseudogene, RNU4-69P is neither a therapeutic target nor functionally relevant in current biomedical literature. - No drugs, mechanisms of action, or disease associations for RNU4-69P are reported. Summary of Evaluation: RNU4-69P is a *non-functional pseudogene* and is not considered a genuine therapeutic, disease, or research target. If you intended to refer to the functional U4 small nuclear RNA gene (e.g., RNU4-2), which is involved in the spliceosome and has established disease associations, RNU4-69P is not the appropriate identifier. For functional or disease-relevant information, use "RNA, U4 small nuclear 2 (RNU4-2)" or another functional U4 snRNA gene[3][4][5][6][7].

Other names

RNU4-69P

None